Vaccinia virus for lung cancer therapy: preclinical progress and prospects as a systemic immunotherapy platform - Poll - MDSpire

Vaccinia virus for lung cancer therapy: preclinical progress and prospects as a systemic immunotherapy platform

  • By

  • Linkai Li

  • Zhongyu Chen

  • Yunrui Yan

  • Lening Zhang

  • May 7, 2026

  • 0 min

Share

Original Source(s)

Vaccinia virus for lung cancer therapy: preclinical progress and prospects as a systemic immunotherapy platform

  • by Linkai Li, Zhongyu Chen, Yunrui Yan, Lening Zhang

  • May 7, 2026

Related Content

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications

Biotech exec Jeremy Levin on the industry’s strategic turning point

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026